1. Home
  2. ASRT vs AIRG Comparison

ASRT vs AIRG Comparison

Compare ASRT & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • AIRG
  • Stock Information
  • Founded
  • ASRT 1995
  • AIRG 1995
  • Country
  • ASRT United States
  • AIRG United States
  • Employees
  • ASRT N/A
  • AIRG N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • AIRG Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ASRT Health Care
  • AIRG Technology
  • Exchange
  • ASRT Nasdaq
  • AIRG Nasdaq
  • Market Cap
  • ASRT 85.1M
  • AIRG 79.4M
  • IPO Year
  • ASRT 1997
  • AIRG 2016
  • Fundamental
  • Price
  • ASRT $0.80
  • AIRG $6.87
  • Analyst Decision
  • ASRT Strong Buy
  • AIRG Strong Buy
  • Analyst Count
  • ASRT 4
  • AIRG 2
  • Target Price
  • ASRT $3.19
  • AIRG $11.75
  • AVG Volume (30 Days)
  • ASRT 357.9K
  • AIRG 32.7K
  • Earning Date
  • ASRT 03-10-2025
  • AIRG 02-27-2025
  • Dividend Yield
  • ASRT N/A
  • AIRG N/A
  • EPS Growth
  • ASRT N/A
  • AIRG N/A
  • EPS
  • ASRT N/A
  • AIRG N/A
  • Revenue
  • ASRT $125,763,000.00
  • AIRG $55,586,000.00
  • Revenue This Year
  • ASRT N/A
  • AIRG $14.12
  • Revenue Next Year
  • ASRT $1.84
  • AIRG $15.47
  • P/E Ratio
  • ASRT N/A
  • AIRG N/A
  • Revenue Growth
  • ASRT N/A
  • AIRG N/A
  • 52 Week Low
  • ASRT $0.73
  • AIRG $3.71
  • 52 Week High
  • ASRT $1.80
  • AIRG $10.34
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 43.92
  • AIRG 44.94
  • Support Level
  • ASRT $0.78
  • AIRG $6.48
  • Resistance Level
  • ASRT $0.83
  • AIRG $7.59
  • Average True Range (ATR)
  • ASRT 0.03
  • AIRG 0.49
  • MACD
  • ASRT 0.00
  • AIRG -0.00
  • Stochastic Oscillator
  • ASRT 39.86
  • AIRG 19.80

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

Share on Social Networks: